VDAC1 as a target in cisplatin anti-tumor activity through promoting mitochondria fusion.
Sign Up to like & getrecommendations! Published in 2021 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2021.04.104
Abstract: Cisplatin is one of the most effective anti-cancer drugs, but its efficacy is limited by the development of resistance. Previous studies have shown that mitochondria play critical roles in cisplatin cytotoxicity, however, the exact mechanism… read more here.
Keywords: vdac1 target; cisplatin; vdac1; fusion ... See more keywords